Quantifying the impact of a large‐scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data‐modeling study
Addiction · 2025
DOI: 10.1111/add.70018 ↗At a glance
Journal article in Addiction, 2025. Written by Thomas James Santo and 8 co-authors. Institution: National Drug and Alcohol Research Centre, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia. Major MEDLINE topics: Opioid-Related Disorders, Suicide Prevention, Opiate Substitution Treatment, Analgesics, Opioid. Cited 1 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: Australian Government Department of Health, NSW Ministry of Health, NIDA NIH HHS.
Abstract (original language)
Aims
This study aimed to quantify the population‐level impact of a large‐scale opioid agonist treatment (OAT) program on suicide‐related mortality among people with opioid use disorder (OUD) in New South Wales (NSW), Australia.
Design
This is the first study to use dynamic mathematical modeling to explore the population‐level impact of OAT on suicide mortality. The study used a two‐part approach. First, we analyzed cohort data (2001–2017) to calculate incidence rate ratios (IRRs) and other model parameters related to OAT and suicide risk. Second, findings were applied to model outputs to estimate suicides averted by the NSW OAT program (2001–2020). Setting and participants A cohort of 46 845 individuals who received OAT between 2001 and 2017 in community and prison settings in New South Wales, Australia.
Measurements
IRRs for suicide and other model parameters were calculated for individuals on versus off OAT in community and prison settings (2001–2017). These estimates, along with model outputs, were used to determine the number and proportion of suicides averted by the OAT program (2001–2020).
Findings
Receiving OAT was associated with an IRR for suicide of 0.32 [95% confidence interval (CI) = 0.25–0.40] in the community and 0.34 (95% CI = 0.10–1.10) in prison for cohort data analyses (2001–2017). Between 2001 and 2020, the OAT program in NSW averted an estimated 338 suicides [95% credible interval (CrI) = 213–492), with 325 (95% CrI = 202–476) averted in the community and 13 (95% CrI = 0–46) in prison, corresponding to a 35% (95% CrI = 27%–43%) reduction in suicides among those accessing OAT.
Conclusions
The opioid agonist treatment program in New South Wales, Australia, was associated with a 35% reduction in suicide mortality among individuals with opioid use disorder receiving treatment between 2001 and 2020, providing novel evidence of its population‐level impact on suicide prevention.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- National Drug and Alcohol Research Centre, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia.
- Division of Infectious Diseases and Global Public Health, School of Medicine, University of California San Diego, San Diego, CA, USA.
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
ORCID profiles: Thomas James Santo, Matthew Hickman, Nicola Jones, Michael Farrell, Chrianna Bharat, Louisa Degenhardt, Annick Borquez
Funding
- Australian Government Department of Health
- NSW Ministry of Health
- NIDA NIH HHS
- James B. Pendleton Charitable Trust
- NIH HHS
- NIAID NIH HHS
- U.S. Department of Veterans Affairs
- the James
Cite
APA
Santo, T. J., Chaillon, A., Martin, N., Hickman, M., Jones, N., Farrell, M., Bharat, C., Degenhardt, L., & Borquez, A. (2025). Quantifying the impact of a large‐scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data‐modeling study. Addiction. https://doi.org/10.1111/add.70018
Vancouver
Santo TJ, Chaillon A, Martin N, Hickman M, Jones N, Farrell M, et al. Quantifying the impact of a large‐scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data‐modeling study. Addiction. 2025. doi:10.1111/add.70018
BibTeX
@article{Santo2025,
author = {Santo, Thomas James and Chaillon, Antoine and Martin, Natasha and Hickman, Matthew and Jones, Nicola and Farrell, Michael and Bharat, Chrianna and Degenhardt, Louisa and Borquez, Annick},
title = {Quantifying the impact of a large‐scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data‐modeling study},
journal = {Addiction},
year = {2025},
doi = {10.1111/add.70018}
}
EUVIMED